IP Library Granted Patent US 8,487,110
Granted Patent B2
US 8,487,110 · App. 12/624,260 · Granted Jul 16, 2013

Method for preparing isofagomine and its derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,487,110
App. No.
12/624,260
Granted
Jul 16, 2013
Kind
B2
Abstract

A method for preparing isofagomine, its derivatives, intermediates and salts thereof using novel processes to make isofagomine from D-(−)-arabinose and L-(−)-xylose.

Claims (10)

1. A method for preparing isofagomine tartrate, comprising protecting the anomeric hydroxyl group of D-(−)-arabinose with a protecting group to form a glycoside; protecting the 2- and 3-hydroxyl groups of said glycoside using a 1,2-dione to form a triprotected arabinose derivative; converting said arabinose derivative to a triprotected xylose derivative; converting said xylose derivative to a triprotected nitrile; converting said nitrile to a protected diol and deprotecting said diol to form isofagomine in the presence of tartaric acid.

2. The method of claim 1 further comprising converting said arabinose derivative to said xylose derivative through an activated system wherein said activated system is optionally isolated before conversion.

3. The method of claim 1 further comprising converting said xylose derivative to said nitrile using an activated system, wherein said activated system is optionally isolated before conversion followed by displacement by a cyano source.

4. The method of claim 1 further comprising obtaining said nitrile after purifying said xylose derivative.

5. The method of claim 1 further comprising converting said arabinose derivative to said xylose derivative by a Mitsunobu inversion reaction to form an inverted ester derivative and saponification.

6. A method for preparing isofagomine tartrate, comprising protecting the anomeric hydroxyl group of D-(−)-arabinose with a protecting group to form a glycoside; protecting the 2- and 3-hydroxyl groups of said glycoside using a 1,2-dione to form a triprotected arabinose derivative; converting said arabinose derivative to a triprotected xylose derivative; converting said xylose derivative to a triprotected nitrile; converting said nitrile in the presence of tartaric acid to a protected isofagomine tartrate salt and deprotecting said isofagomine tartrate salt.

7. A method for preparing isofagomine tartrate, comprising protecting the anomeric hydroxyl group of D-(−)-arabinose with a protecting group to form a glycoside; protecting the 2- and 3-hydroxyl groups of said glycoside using a 1,2-dione to form a triprotected arabinose derivative; converting said arabinose derivative to a triprotected xylose derivative; converting said xylose derivative to a triprotected nitrile; reducing said nitrile to a triprotected primary amine; deprotecting said primary amine to a diol; and subjecting the diol to catalytic hydrogenation in the presence of tartaric acid.

8. The method of claim 1 wherein protecting of said anomeric hydroxyl group of D-(−)-arabinose is accomplished using an alcohol, an activating agent and optionally a solvent; and formation of said arabinose derivative is accomplished using an acid and an alcohol.

9. The method of claim 6 wherein protecting of said anomeric hydroxyl group of D-(−)-arabinose is accomplished using an alcohol, an activating agent and optionally a solvent; and formation of said arabinose derivative is accomplished using an acid and an alcohol.

10. The method of claim 7 wherein protecting of said anomeric hydroxyl group of D-(−)-arabinose is accomplished using an alcohol, an activating agent and optionally a solvent; and formation of said arabinose derivative is accomplished using an acid and an alcohol.

Assignments (3)
SECURITY INTEREST Recorded Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2012
From: SHETH, KAMLESH
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 029451/0292 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2010
From: RYBCZYNSKI, PHILIP; TRETYAKOV, ALEXANDER; FUERST, DAN
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 024123/0015 →